Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.
J Butler, M Packer, G Filippatos, JP Ferreira… - European Heart …, 2022 - europepmc.org
Aims No therapy has shown to reduce the risk of hospitalization for heart failure across the
entire range of ejection fractions seen in clinical practice. We assessed the influence of …
entire range of ejection fractions seen in clinical practice. We assessed the influence of …
[PDF][PDF] Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
J Butler, M Packer, G Filippatos, JP Ferreira, C Zeller… - scholar.archive.org
Aims No therapy has shown to reduce the risk of hospitalization for heart failure across the
entire range of ejection fractions seen in clinical practice. We assessed the influence of …
entire range of ejection fractions seen in clinical practice. We assessed the influence of …
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
J Butler, M Packer, G Filippatos, JP Ferreira… - European Heart …, 2021 - hal.univ-lorraine.fr
Aims No therapy has shown to reduce the risk of hospitalization for heart failure across the
entire range of ejection fractions seen in clinical practice. We assessed the influence of …
entire range of ejection fractions seen in clinical practice. We assessed the influence of …
[PDF][PDF] Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
J Butler, M Packer, G Filippatos, JP Ferreira, C Zeller… - 116683.com
Aims No therapy has shown to reduce the risk of hospitalization for heart failure across the
entire range of ejection fractions seen in clinical practice. We assessed the influence of …
entire range of ejection fractions seen in clinical practice. We assessed the influence of …